Glanmark Pharmaceuticals said on Thursday its unit has received U.S. FDA approval for clotrimazole cream.
Clotrimazole cream, used to in the treatment of candidiasis, had annual sales of $26 million in the U.S., it said in a statement.
Clotrimazole cream is equivalent to Taro Pharmaceutical Industries'TAROF.PK branded cream Clotrimazole, it added.
No comments:
Post a Comment